Endo Pharmaceuticals Inc. is committed to developing innovative products for unmet medical needs. As part of the development process, Endo Pharmaceuticals Inc. conduct clinical research to help determine the safety and efficacy of medications and conducts research with the intent of learning more about treatment options, disease states, diagnostics, and other associated issues that contribute to the health and well being of patients. This research often occurs in the form of clinical trials that may, or may not, relate to uses that have been studied and approved by various regulatory agencies around the world. The information contained in this web site is not intended to promote or otherwise commercialize any off-label or unapproved uses of medicines developed by Endo Pharmaceuticals Inc. The company strives to maintain the highest ethical, scientific, and clinical standards in all of our clinical research. We are committed to the timely registration of clinical trials in patients and the disclosure of associated clinical results, regardless of outcome. All clinical studies of Endo Pharmaceuticals Inc.’s drugs, biologics, or devices, as required under federal and state regulations, are registered on www.clinicaltrials.gov. This site contains clinical trial results of hypothesis-testing (Phase II to IV) clinical trials initiated after October 15, 2002 and completed before December 25, 2007 for marketed Endo Pharmaceutical Inc. products. The company also posts detailed results of its Phase II-IV clinical investigations, initiated or ongoing as of September 27, 2007, or later, to www.clinicaltrials.gov. The information contained in this site is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, please consult your physician. To access the Clinical Trial results please click here.
